Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105208

Clinical Significance of a Hydroxyproline-containing Protein in Human Plasma

E. Carwile LeRoy and Albert Sjoerdsma

Experimental Therapeutics Branch, National Heart Institute, Bethesda, Md.

†

Address requests for reprints to Dr. Albert Sjoerdsma, National Heart Institute, Bethesda, Md. 20014.

*

Submitted for publication December 18, 1964; accepted February 15, 1965.

Find articles by LeRoy, E. in: JCI | PubMed | Google Scholar

Experimental Therapeutics Branch, National Heart Institute, Bethesda, Md.

†

Address requests for reprints to Dr. Albert Sjoerdsma, National Heart Institute, Bethesda, Md. 20014.

*

Submitted for publication December 18, 1964; accepted February 15, 1965.

Find articles by Sjoerdsma, A. in: JCI | PubMed | Google Scholar

Published June 1, 1965 - More info

Published in Volume 44, Issue 6 on June 1, 1965
J Clin Invest. 1965;44(6):914–919. https://doi.org/10.1172/JCI105208.
© 1965 The American Society for Clinical Investigation
Published June 1, 1965 - Version history
View PDF
Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 914
page 914
icon of scanned page 915
page 915
icon of scanned page 916
page 916
icon of scanned page 917
page 917
icon of scanned page 918
page 918
icon of scanned page 919
page 919
Version history
  • Version 1 (June 1, 1965): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts